メニュを開く メニュ
文字サイズ 標準

2022年

≪2022年≫

<論文>

  1. A case of juvenile-onset pheochromocytoma with KIF1B p.V1529M germline mutation.
    Nezu M, Hirotsu Y, Amemiya K, Katsumata M, Watanabe T, Takizawa S, Inoue M, Mochizuki H, Hosaka K, Oyama T, Omata M.
    Endocr J. 2022 in press
  2. Non-pharmaceutical interventions during the COVID-19 epidemic changed detection rates of other circulating respiratory pathogens in Japan.
    Nagakubo Y, Hirotsu Y, Maejima M, Shibusawa M, Hosaka K, Amemiya K, Sueki H, Hayakawa M, Mochizuki H, Tsutsui T, Kakizaki Y, Miyashita Y, Omata M.
    PLoS One. 2022;17(1):e0262874.
  3. Direct comparison of Xpert Xpress, FilmArray Respiratory Panel, Lumipulse antigen test, and RT-qPCR in 165 nasopharyngeal swabs.
    Hirotsu Y, Maejima M, Shibusawa M, Natori Y, Nagakubo Y, Hosaka K, Sueki H, Amemiya K, Hayakawa M, Mochizuki H, Tsutsui T, Kakizaki Y, Miyashita Y, Omata M.
    BMC Infect Dis. 2022;22(1):221.
  4. PIK3CA-AKT pathway predominantly acts in developing ipsilateral breast tumor recurrence long after breast-conserving surgery.
    Nakagomi H, Inoue M, Hirotsu Y, Amemiya K, Mochiduki H, Omata M.
    Breast Cancer Res Treat. 2022 in press

<学会発表>

作成中

ページの
先頭に戻る